a
Please contact us for any questions.
+41 78 856 4585

Related Posts

Cutting Edge Service

A novel tailored heart valve selection service for each individual patient before the heart valve replacement

We engineer imaging techniques for patients with aortic stenosis by providing unique solutions for each individual before cardiac surgery based on their specific physiology.  

The novel approach we offer provides the doctor an aortic valve selection service that will increase the success rate of the aortic valve replacement surgery, as well as decreasing the complications after the surgery.

Touching Your Heart

Our pre-operational support tool allows the doctor to select the optimum size and shape of the ideal heart valve for patient-specific anatomies before the trans-catheter aortic valve implantation.

Inspiring Better Health

The novel technology developed by Hi-D Imaging helps patients with aortic stenosis. Our service targets to improve patient outcome, disease management, diagnosis and treatment, and decrease treatment costs.

We Care For Your Heart

A novel in-vitro approach to overcome the limitations of conventional medical imaging tools and to go beyond the capabilities of these tools.

Alarming conditions from the heart of the community

In Switzerland, the life expectancy for men is 81.4 years and for women is 85.4 years (at birth). However, healthy life expectancy is 69.8 years for men and 70.8 years for women. This shows that 30.5% of men and 34.7% of women in Switzerland have long-standing health problems.

Cardiovascular diseases 0
Cancer 0
Dementia 0
Accidents 0
Other 0

Widespread application of the new generation aortic valves

Transcatheter aortic-valve implantation (TAVI) is a novel method for patients with severe aortic stenosis who are not candidates for open-heart surgery or who are at high risk for complications due to surgery.

In Europe, Switzerland and Germany are the largest markets with the highest number of TAV implants per million, highest healthcare spend per capita, and highest TAV penetration rates.

Switzerland 0
Germany 0

Precise. Accurate. High dimensional.

Our state-of-the-art heart valve selection service supports healthcare professionals before the cardiac surgery. It is based on analyzing the blood flow patterns in vitro using an optical imaging technique within an anatomically accurate silicone model produced using CT scans of the patients.

The four-step process is effective, low-cost and fast for the clinicians:

  1. Acquisition of anatomy using the CT scan data of the patient
  2. 3D-print of the silicone model
  3. Performance analysis of different heart valves
  4. Reporting of the results to the clinician.
Creating a healthier world together

We will provide complementary information to clinical doctors to help their selection of an optimal heart valve for each individual patient. As the implementation of the valve will be done by the doctors, the decision of the selection of the valve will be given by the doctors as well, based on our report.

In the scope our service, we will closely work with the clinicians and provide all the information necessary for their selection process. The communication between the doctor and the patient, including the decision of receiving our service, selection of the valve, and discussion of the results, will be led by the doctor.

Knowledge makes all the difference

Our service for the medical companies differs from our service for the clinicians based on our consulting type. Every few years, medical companies design new heart valves to improve upon their previous designs.

We offer performance tests and provide consulting service to their new generation heart valves before they release their product into the market which will add significant value to the products of the medical companies.

Caring for every individual’s life

The major gap between the medical imaging and the aortic valve surgery is the lack of information on the patient’s specific hemodynamics. The current procedure is such that the clinical doctors receive limited information from conventional imaging tools before selection of the heart valves, which may cause major after-surgery complications.

These complications not only decrease the success rate of the surgery, but also significantly impact the patient’s life by increasing additional costs and their life quality as well as reducing complications, length of the hospital stays, and additional costs to the national health system.

49
After Surgery Complications

49% of all patients experience after surgery complications following transcatheter aortic valve implementation.

42
Paravalvular Leakage

The most common after TAV operation is paravalvular leakage

28
Patient Prosthetic Mismatch

A large number of the patients suffer from prosthetic mismatch

16
Thrombo-embolism

A very common complication after TAVI

Our Testimonials

Testimonials from key opinion leaders

In order to optimize clinical outcomes and patient well-being, we increasingly need personalized  approaches in medicine. This is exactly what Hi-D Imaging is doing for the growing market of percutaneously inserted artificial heart valves. 
Firat Duru, MD
Senior Cardiologist and Scientist, UniSpital Zürich
The tool developed by Hi-D Imaging will be invaluable not only in the selection of the most appropriate commercially available valves, but also for companies (like SAT) who are developing new and innovative heart valves and repair devices
Deon Bezuidenhout
Technical Director, Strait Access Technologies (SAT)